한글목차

세계 코르티코스테로이드 API 시장 규모는 2022년 22억 626만 달러에서 예측 기간 동안 6.11%의 CAGR을 기록하며 2029년에는 33억 940만 달러 규모로 성장할 것으로 예상됩니다.

북미 시장은 2022년 2억 2,053만 달러에서 4.69%의 CAGR로 2029년에는 3억 218만 달러에 달할 것으로 예상됩니다. 유럽 시장은 2022년 5억 1,279만 달러에서 4.74%의 CAGR을 기록하며 2029년에는 7억 819만 달러에 달할 것으로 예상됩니다.

세계 코르티코스테로이드 API 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추이 및 예측, 유형별·용도별 분석, 지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 코르티코스테로이드 API : 시장 개요

• 제품의 정의
• 코르티코스테로이드 API : 유형별
  • 성장률 분석 : 2022 vs 2029
  • 프레드니손 시리즈
  • 덱사메타손 시리즈
  • 베타메타손 시리즈
  • 하이드로코르티손 시리즈
  • 기타
• 코르티코스테로이드 API : 용도별
  • 성장률 분석 : 2022 vs 2029
  • 주사제
  • 경구제
  • 외용제
  • 흡입제
• 세계 시장 성장 전망
  • 제조액 추정과 예측
  • 제조능력 추정과 예측
  • 제조량 추정과 예측
  • 평균 가격 추정과 예측
• 가정·제한

제2장 경쟁 상황 : 주요 기업별

• 제조량 점유율 : 제조업체별
• 제조액 점유율 : 제조업체별
• 세계의 주요 기업 : 업계 순위
• 시장 점유율 : 기업 유형별
• 평균 가격 : 제조업체별
• 세계의 주요 제조업체 : 서비스 제공 지역 및 본사
• 세계의 주요 제조업체 : 제공 제품·용도
• 세계의 주요 제조업체 : 설립일
• 경쟁 상황·동향
• M&A·확대

제3장 코르티코스테로이드 API 제조 동향 : 지역별

• 제조액 추정과 예측 : 지역별 : 2018년 vs 2022년 vs 2029년
• 제조액 추정과 예측·시장 점유율 : 지역별
• 제조량 추정과 예측 : 지역별 : 2018년 vs 2022년 vs 2029년
• 제조량 추정과 예측·시장 점유율 : 지역별
• 가격 분석 : 지역별
• 제조량·제조액·전년비 성장률
  • 북미
  • 유럽
  • 중국
  • 일본

제4장 코르티코스테로이드 API 소비 동향 : 지역별

• 소비량 추정과 예측 : 지역별 : 2018년 vs 2022년 vs 2029년
• 소비량 추정과 예측 : 지역별
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카, 중동 및 아프리카

제5장 유형별 부문

• 제조량 추정과 예측·시장 점유율
• 제조액 추정과 예측·시장 점유율
• 가격 추정과 예측

제6장 용도별 부문

• 제조량 추정과 예측·시장 점유율
• 제조액 추정과 예측·시장 점유율
• 가격 추정과 예측

제7장 주요 기업 개요

• Pfizer CentreOne
• EUROAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid SpA
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab
• Sun Pharmaceutical
• Cipla
• Wellona Pharma
• Tianjin Tianyao Pharmaceuticals
• Zhejiang Xianju Pharmaceutical
• Guangdong VTR BioTech
• Zhejiang Xianju Xianle Pharmaceutical
• Shandong Xinhua Pharmaceutica Group
• Jiangsu Lianhuan Pharmaceutical
• Shanghai New Hualian Pharmaceutical
• Shandong Taihua Biotech
• Shandong Sito Bio-technolog
• Zhejiang Xianju Junye Pharmaceutical

제8장 산업 체인과 판매 채널 분석

• 산업 체인 분석
• 주요 원재료
• 제조 모드·프로세스
• 판매·마케팅
• 고객

제9장 코르티코스테로이드 API : 시장 역학

• 업계 동향
• 시장 성장 촉진요인
• 시장 과제
• 시장 성장 억제요인

제10장 조사 결과와 결론

제11장 조사 방법과 정보 출처

영문목차

The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029.

North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029.

Europe market for Corticosteroids API is estimated to increase from $ 512.79 million in 2022 to reach $ 708.19 million by 2029, at a CAGR of 4.74 % during the forecast period of 2023 through 2029.

The major global manufacturers of Corticosteroids API include: Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Teva Pharmaceutical Industries, Hovione, Axplora, Steroid SpA, Avik Pharmaceutical, and Anuh Pharma, etc. In 2022, the world's top three vendors accounted for approximately 30.09% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Corticosteroids API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroids API.

The Corticosteroids API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Corticosteroids API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Corticosteroids API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

• Pfizer CentreOne
• EUROAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid SpA
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab
• Sun Pharmaceutical
• Cipla
• Wellona Pharma
• Tianjin Tianyao Pharmaceuticals
• Zhejiang Xianju Pharmaceutical
• Guangdong VTR BioTech
• Zhejiang Xianju Xianle Pharmaceutical
• Tianjin Pacific Pharmaceutical
• Shandong Xinhua Pharmaceutica Group
• Jiangsu Lianhuan Pharmaceutical
• Shanghai New Hualian Pharmaceutical
• Shandong Taihua Biotech
• Shandong Sito Bio-technolog
• Zhejiang Xianju Junye Pharmaceutical

Segment by Type

• Prednisone Series
• Dexamethasone Series
• Betamethasone Series
• Hydrocortisone Series
• Other

Segment by Application

• Injectable Drugs
• Oral Drugs
• Topical Drugs
• Inhaled Drugs

Production by Region

• North America
• Europe
• China
• Japan

Consumption by Region

• North America
  • U.S.
  • Canada

• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India

• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe

• South America
  • Mexico
  • Brazil
  • Rest of South America

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Corticosteroids API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Corticosteroids API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Corticosteroids API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Corticosteroids API Market Overview

• 1.1 Product Definition
• 1.2 Corticosteroids API by Type
  • 1.2.1 Global Corticosteroids API Market Value Growth Rate Analysis by Type: 2022 VS 2029
  • 1.2.2 Prednisone Series
  • 1.2.3 Dexamethasone Series
  • 1.2.4 Betamethasone Series
  • 1.2.5 Hydrocortisone Series
  • 1.2.6 Other
• 1.3 Corticosteroids API by Application
  • 1.3.1 Global Corticosteroids API Market Value Growth Rate Analysis by Application: 2022 VS 2029
  • 1.3.2 Injectable Drugs
  • 1.3.3 Oral Drugs
  • 1.3.4 Topical Drugs
  • 1.3.5 Inhaled Drugs
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Corticosteroids API Production Value Estimates and Forecasts (2018-2029)
  • 1.4.2 Global Corticosteroids API Production Capacity Estimates and Forecasts (2018-2029)
  • 1.4.3 Global Corticosteroids API Production Estimates and Forecasts (2018-2029)
  • 1.4.4 Global Corticosteroids API Market Average Price Estimates and Forecasts (2018-2029)
• 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

• 2.1 Global Corticosteroids API Production Market Share by Manufacturers (2018-2023)
• 2.2 Global Corticosteroids API Production Value Market Share by Manufacturers (2018-2023)
• 2.3 Global Key Players of Corticosteroids API, Industry Ranking, 2021 VS 2022
• 2.4 Global Corticosteroids API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.5 Global Corticosteroids API Average Price by Manufacturers (2018-2023)
• 2.6 Global Key Manufacturers of Corticosteroids API, Area Served and Headquarters
• 2.7 Global Key Manufacturers of Corticosteroids API, Product Offered and Application
• 2.8 Global Key Manufacturers of Corticosteroids API, Establishment Date
• 2.9 Corticosteroids API Market Competitive Situation and Trends
  • 2.9.1 Corticosteroids API Market Concentration Rate
  • 2.9.2 Global 5 and 10 Largest Corticosteroids API Players Market Share by Revenue
• 2.10 Mergers & Acquisitions, Expansion

3 Corticosteroids API Production by Region

• 3.1 Global Corticosteroids API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
• 3.2 Global Corticosteroids API Production Value by Region (2018-2029)
  • 3.2.1 Global Corticosteroids API Production Value Market Share by Region (2018-2023)
  • 3.2.2 Global Forecasted Production Value of Corticosteroids API by Region (2024-2029)
• 3.3 Global Corticosteroids API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
• 3.4 Global Corticosteroids API Production by Region (2018-2029)
  • 3.4.1 Global Corticosteroids API Production Market Share by Region (2018-2023)
  • 3.4.2 Global Forecasted Production of Corticosteroids API by Region (2024-2029)
• 3.5 Global Corticosteroids API Market Price Analysis by Region (2018-2023)
• 3.6 Global Corticosteroids API Production and Value, Year-over-Year Growth
  • 3.6.1 North America Corticosteroids API Production Value Estimates and Forecasts (2018-2029)
  • 3.6.2 Europe Corticosteroids API Production Value Estimates and Forecasts (2018-2029)
  • 3.6.3 China Corticosteroids API Production Value Estimates and Forecasts (2018-2029)
  • 3.6.4 Japan Corticosteroids API Production Value Estimates and Forecasts (2018-2029)

4 Corticosteroids API Consumption by Region

• 4.1 Global Corticosteroids API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
• 4.2 Global Corticosteroids API Consumption by Region (2018-2029)
  • 4.2.1 Global Corticosteroids API Consumption by Region (2018-2029)
  • 4.2.2 Global Corticosteroids API Forecasted Consumption by Region (2024-2029)
• 4.3 North America
  • 4.3.1 North America Corticosteroids API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  • 4.3.2 North America Corticosteroids API Consumption by Country (2018-2029)
  • 4.3.3 U.S.
  • 4.3.4 Canada
• 4.4 Europe
  • 4.4.1 Europe Corticosteroids API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  • 4.4.2 Europe Corticosteroids API Consumption by Country (2018-2029)
  • 4.4.3 Germany
  • 4.4.4 U.K.
  • 4.4.5 France
  • 4.4.6 Russia
  • 4.4.7 Italy
• 4.5 Asia Pacific
  • 4.5.1 Asia Pacific Corticosteroids API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  • 4.5.2 Asia Pacific Corticosteroids API Consumption by Region (2018-2029)
  • 4.5.3 China
  • 4.5.4 Japan
  • 4.5.5 South Korea
  • 4.5.6 India
  • 4.5.7 Southeast Asia
• 4.6 Latin America, Middle East & Africa
  • 4.6.1 Latin America, Middle East & Africa Corticosteroids API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  • 4.6.2 Latin America, Middle East & Africa Corticosteroids API Consumption by Country (2018-2029)
  • 4.6.3 Mexico
  • 4.6.4 Brazil
  • 4.6.5 Turkey
  • 4.6.6 GCC Countries

5 Segment by Type

• 5.1 Global Corticosteroids API Production by Type (2018-2029)
  • 5.1.1 Global Corticosteroids API Production by Type (2018-2023)
  • 5.1.2 Global Corticosteroids API Production by Type (2024-2029)
  • 5.1.3 Global Corticosteroids API Production Market Share by Type (2018-2029)
• 5.2 Global Corticosteroids API Production Value by Type (2018-2029)
  • 5.2.1 Global Corticosteroids API Production Value by Type (2018-2023)
  • 5.2.2 Global Corticosteroids API Production Value by Type (2024-2029)
  • 5.2.3 Global Corticosteroids API Production Value Market Share by Type (2018-2029)
• 5.3 Global Corticosteroids API Price by Type (2018-2029)

6 Segment by Application

• 6.1 Global Corticosteroids API Production by Application (2018-2029)
  • 6.1.1 Global Corticosteroids API Production by Application (2018-2023)
  • 6.1.2 Global Corticosteroids API Production by Application (2024-2029)
  • 6.1.3 Global Corticosteroids API Production Market Share by Application (2018-2029)
• 6.2 Global Corticosteroids API Production Value by Application (2018-2029)
  • 6.2.1 Global Corticosteroids API Production Value by Application (2018-2023)
  • 6.2.2 Global Corticosteroids API Production Value by Application (2024-2029)
  • 6.2.3 Global Corticosteroids API Production Value Market Share by Application (2018-2029)
• 6.3 Global Corticosteroids API Price by Application (2018-2029)

7 Key Companies Profiled

• 7.1 Pfizer CentreOne
  • 7.1.1 Pfizer CentreOne Corticosteroids API Company Information
  • 7.1.2 Pfizer CentreOne Corticosteroids API Product Portfolio
  • 7.1.3 Pfizer CentreOne Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.1.4 Pfizer CentreOne Main Business and Markets Served
  • 7.1.5 Pfizer CentreOne Recent Developments/Updates
• 7.2 EUROAPI
  • 7.2.1 EUROAPI Corticosteroids API Company Information
  • 7.2.2 EUROAPI Corticosteroids API Product Portfolio
  • 7.2.3 EUROAPI Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.2.4 EUROAPI Main Business and Markets Served
  • 7.2.5 EUROAPI Recent Developments/Updates
• 7.3 GlaxoSmithKline
  • 7.3.1 GlaxoSmithKline Corticosteroids API Company Information
  • 7.3.2 GlaxoSmithKline Corticosteroids API Product Portfolio
  • 7.3.3 GlaxoSmithKline Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.3.4 GlaxoSmithKline Main Business and Markets Served
  • 7.3.5 GlaxoSmithKline Recent Developments/Updates
• 7.4 Teva Pharmaceutical Industries
  • 7.4.1 Teva Pharmaceutical Industries Corticosteroids API Company Information
  • 7.4.2 Teva Pharmaceutical Industries Corticosteroids API Product Portfolio
  • 7.4.3 Teva Pharmaceutical Industries Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.4.4 Teva Pharmaceutical Industries Main Business and Markets Served
  • 7.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
• 7.5 Hovione
  • 7.5.1 Hovione Corticosteroids API Company Information
  • 7.5.2 Hovione Corticosteroids API Product Portfolio
  • 7.5.3 Hovione Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.5.4 Hovione Main Business and Markets Served
  • 7.5.5 Hovione Recent Developments/Updates
• 7.6 Axplora
  • 7.6.1 Axplora Corticosteroids API Company Information
  • 7.6.2 Axplora Corticosteroids API Product Portfolio
  • 7.6.3 Axplora Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.6.4 Axplora Main Business and Markets Served
  • 7.6.5 Axplora Recent Developments/Updates
• 7.7 Steroid SpA
  • 7.7.1 Steroid SpA Corticosteroids API Company Information
  • 7.7.2 Steroid SpA Corticosteroids API Product Portfolio
  • 7.7.3 Steroid SpA Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.7.4 Steroid SpA Main Business and Markets Served
• 7.8 Avik Pharmaceutical
  • 7.8.1 Avik Pharmaceutical Corticosteroids API Company Information
  • 7.8.2 Avik Pharmaceutical Corticosteroids API Product Portfolio
  • 7.8.3 Avik Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.8.4 Avik Pharmaceutical Main Business and Markets Served
• 7.9 Anuh Pharma
  • 7.9.1 Anuh Pharma Corticosteroids API Company Information
  • 7.9.2 Anuh Pharma Corticosteroids API Product Portfolio
  • 7.9.3 Anuh Pharma Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.9.4 Anuh Pharma Main Business and Markets Served
• 7.10 Symbiotec Pharmalab
  • 7.10.1 Symbiotec Pharmalab Corticosteroids API Company Information
  • 7.10.2 Symbiotec Pharmalab Corticosteroids API Product Portfolio
  • 7.10.3 Symbiotec Pharmalab Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.10.4 Symbiotec Pharmalab Main Business and Markets Served
• 7.11 Sun Pharmaceutical
  • 7.11.1 Sun Pharmaceutical Corticosteroids API Company Information
  • 7.11.2 Sun Pharmaceutical Corticosteroids API Product Portfolio
  • 7.11.3 Sun Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.11.4 Sun Pharmaceutical Main Business and Markets Served
  • 7.11.5 Sun Pharmaceutical Recent Developments/Updates
• 7.12 Cipla
  • 7.12.1 Cipla Corticosteroids API Company Information
  • 7.12.2 Cipla Corticosteroids API Product Portfolio
  • 7.12.3 Cipla Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.12.4 Cipla Main Business and Markets Served
• 7.13 Wellona Pharma
  • 7.13.1 Wellona Pharma Corticosteroids API Company Information
  • 7.13.2 Wellona Pharma Corticosteroids API Product Portfolio
  • 7.13.3 Wellona Pharma Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.13.4 Wellona Pharma Main Business and Markets Served
• 7.14 Tianjin Tianyao Pharmaceuticals
  • 7.14.1 Tianjin Tianyao Pharmaceuticals Corticosteroids API Company Information
  • 7.14.2 Tianjin Tianyao Pharmaceuticals Corticosteroids API Product Portfolio
  • 7.14.3 Tianjin Tianyao Pharmaceuticals Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.14.4 Tianjin Tianyao Pharmaceuticals Main Business and Markets Served
  • 7.14.5 Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
• 7.15 Zhejiang Xianju Pharmaceutical
  • 7.15.1 Zhejiang Xianju Pharmaceutical Corticosteroids API Company Information
  • 7.15.2 Zhejiang Xianju Pharmaceutical Corticosteroids API Product Portfolio
  • 7.15.3 Zhejiang Xianju Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.15.4 Zhejiang Xianju Pharmaceutical Main Business and Markets Served
  • 7.15.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
• 7.16 Guangdong VTR BioTech
  • 7.16.1 Guangdong VTR BioTech Corticosteroids API Company Information
  • 7.16.2 Guangdong VTR BioTech Corticosteroids API Product Portfolio
  • 7.16.3 Guangdong VTR BioTech Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.16.4 Guangdong VTR BioTech Main Business and Markets Served
  • 7.16.5 Guangdong VTR BioTech Recent Developments/Updates
• 7.17 Zhejiang Xianju Xianle Pharmaceutical
  • 7.17.1 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Company Information
  • 7.17.2 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Product Portfolio
  • 7.17.3 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.17.4 Zhejiang Xianju Xianle Pharmaceutical Main Business and Markets Served
• 7.18 Tianjin Pacific Pharmaceutical
  • 7.18.1 Tianjin Pacific Pharmaceutical Corticosteroids API Company Information
  • 7.18.2 Tianjin Pacific Pharmaceutical Corticosteroids API Product Portfolio
  • 7.18.3 Tianjin Pacific Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.18.4 Tianjin Pacific Pharmaceutical Main Business and Markets Served
• 7.19 Shandong Xinhua Pharmaceutica Group
  • 7.19.1 Shandong Xinhua Pharmaceutica Group Corticosteroids API Company Information
  • 7.19.2 Shandong Xinhua Pharmaceutica Group Corticosteroids API Product Portfolio
  • 7.19.3 Shandong Xinhua Pharmaceutica Group Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.19.4 Shandong Xinhua Pharmaceutica Group Main Business and Markets Served
• 7.20 Jiangsu Lianhuan Pharmaceutical
  • 7.20.1 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Company Information
  • 7.20.2 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Product Portfolio
  • 7.20.3 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.20.4 Jiangsu Lianhuan Pharmaceutical Main Business and Markets Served
  • 7.20.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
• 7.21 Shanghai New Hualian Pharmaceutical
  • 7.21.1 Shanghai New Hualian Pharmaceutical Corticosteroids API Company Information
  • 7.21.2 Shanghai New Hualian Pharmaceutical Corticosteroids API Product Portfolio
  • 7.21.3 Shanghai New Hualian Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.21.4 Shanghai New Hualian Pharmaceutical Main Business and Markets Served
• 7.22 Shandong Taihua Biotech
  • 7.22.1 Shandong Taihua Biotech Corticosteroids API Company Information
  • 7.22.2 Shandong Taihua Biotech Corticosteroids API Product Portfolio
  • 7.22.3 Shandong Taihua Biotech Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.22.4 Shandong Taihua Biotech Main Business and Markets Served
• 7.23 Shandong Sito Bio-technolog
  • 7.23.1 Shandong Sito Bio-technolog Corticosteroids API Company Information
  • 7.23.2 Shandong Sito Bio-technolog Corticosteroids API Product Portfolio
  • 7.23.3 Shandong Sito Bio-technolog Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.23.4 Shandong Sito Bio-technolog Main Business and Markets Served
• 7.24 Zhejiang Xianju Junye Pharmaceutical
  • 7.24.1 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Company Information
  • 7.24.2 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Product Portfolio
  • 7.24.3 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Production, Value, Price and Gross Margin (2018-2023)
  • 7.24.4 Zhejiang Xianju Junye Pharmaceutical Main Business and Markets Served

8 Industry Chain and Sales Channels Analysis

• 8.1 Corticosteroids API Industry Chain Analysis
• 8.2 Corticosteroids API Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 Corticosteroids API Production Mode & Process
• 8.4 Corticosteroids API Sales and Marketing
  • 8.4.1 Corticosteroids API Sales Channels
  • 8.4.2 Corticosteroids API Distributors
• 8.5 Corticosteroids API Customers

9 Corticosteroids API Market Dynamics

• 9.1 Corticosteroids API Industry Trends
• 9.2 Corticosteroids API Market Drivers
• 9.3 Corticosteroids API Market Challenges
• 9.4 Corticosteroids API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

• 11.1 Methodology/Research Approach
  • 11.1.1 Research Programs/Design
  • 11.1.2 Market Size Estimation
  • 11.1.3 Market Breakdown and Data Triangulation
• 11.2 Data Source
  • 11.2.1 Secondary Sources
  • 11.2.2 Primary Sources
• 11.3 Author List
• 11.4 Disclaimer